BIIB
Price
$133.13
Change
+$2.77 (+2.12%)
Updated
Jun 6 closing price
Capitalization
31.34B
44 days until earnings call
OGN
Price
$9.56
Change
+$0.37 (+4.03%)
Updated
Jun 6 closing price
Capitalization
4.73B
64 days until earnings call
Interact to see
Advertisement

BIIB vs OGN

Header iconBIIB vs OGN Comparison
Open Charts BIIB vs OGNBanner chart's image
Biogen
Price$133.13
Change+$2.77 (+2.12%)
Volume$1.17M
Capitalization31.34B
Organon & Co
Price$9.56
Change+$0.37 (+4.03%)
Volume$6.55M
Capitalization4.73B
BIIB vs OGN Comparison Chart
Loading...
BIIB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BIIB vs. OGN commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIIB is a Buy and OGN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (BIIB: $127.53 vs. OGN: $9.15)
Brand notoriety: BIIB: Notable vs. OGN: Not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: BIIB: 91% vs. OGN: 76%
Market capitalization -- BIIB: $31.34B vs. OGN: $4.73B
BIIB [@Pharmaceuticals: Major] is valued at $31.34B. OGN’s [@Pharmaceuticals: Major] market capitalization is $4.73B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIIB’s FA Score shows that 0 FA rating(s) are green whileOGN’s FA Score has 2 green FA rating(s).

  • BIIB’s FA Score: 0 green, 5 red.
  • OGN’s FA Score: 2 green, 3 red.
According to our system of comparison, OGN is a better buy in the long-term than BIIB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIIB’s TA Score shows that 5 TA indicator(s) are bullish while OGN’s TA Score has 5 bullish TA indicator(s).

  • BIIB’s TA Score: 5 bullish, 3 bearish.
  • OGN’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, OGN is a better buy in the short-term than BIIB.

Price Growth

BIIB (@Pharmaceuticals: Major) experienced а +0.56% price change this week, while OGN (@Pharmaceuticals: Major) price change was +8.54% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +2.22%. For the same industry, the average monthly price growth was +3.78%, and the average quarterly price growth was +3.49%.

Reported Earning Dates

BIIB is expected to report earnings on Jul 23, 2025.

OGN is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+2.22% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BIIB($31.3B) has a higher market cap than OGN($4.73B). BIIB has higher P/E ratio than OGN: BIIB (26.95) vs OGN (4.64). BIIB YTD gains are higher at: -16.603 vs. OGN (-37.400). BIIB has higher annual earnings (EBITDA): 2.04B vs. OGN (1.44B). BIIB has more cash in the bank: 1.05B vs. OGN (693M). BIIB has less debt than OGN: BIIB (7.34B) vs OGN (8.76B). BIIB has higher revenues than OGN: BIIB (9.84B) vs OGN (6.26B).
BIIBOGNBIIB / OGN
Capitalization31.3B4.73B662%
EBITDA2.04B1.44B142%
Gain YTD-16.603-37.40044%
P/E Ratio26.954.64581%
Revenue9.84B6.26B157%
Total Cash1.05B693M152%
Total Debt7.34B8.76B84%
FUNDAMENTALS RATINGS
BIIB: Fundamental Ratings
BIIB
OUTLOOK RATING
1..100
9
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
67
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
96
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BIIBOGN
RSI
ODDS (%)
N/A
Bullish Trend 13 days ago
64%
Stochastic
ODDS (%)
Bearish Trend 13 days ago
67%
Bearish Trend 13 days ago
74%
Momentum
ODDS (%)
Bullish Trend 13 days ago
53%
Bullish Trend 13 days ago
65%
MACD
ODDS (%)
N/A
Bullish Trend 13 days ago
72%
TrendWeek
ODDS (%)
Bearish Trend 13 days ago
70%
Bullish Trend 13 days ago
67%
TrendMonth
ODDS (%)
Bullish Trend 13 days ago
56%
Bearish Trend 13 days ago
69%
Advances
ODDS (%)
Bullish Trend 21 days ago
54%
Bullish Trend 13 days ago
67%
Declines
ODDS (%)
Bearish Trend 19 days ago
70%
Bearish Trend 20 days ago
73%
BollingerBands
ODDS (%)
Bearish Trend 13 days ago
74%
Bullish Trend 13 days ago
68%
Aroon
ODDS (%)
Bullish Trend 13 days ago
50%
Bearish Trend 13 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
BIIB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

BIIB and

Correlation & Price change

A.I.dvisor indicates that over the last year, BIIB has been loosely correlated with AMGN. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if BIIB jumps, then AMGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIIB
1D Price
Change %
BIIB100%
-0.67%
AMGN - BIIB
51%
Loosely correlated
-0.38%
NVS - BIIB
47%
Loosely correlated
-1.18%
PFE - BIIB
45%
Loosely correlated
-1.82%
MRK - BIIB
41%
Loosely correlated
-1.83%
SNY - BIIB
41%
Loosely correlated
-0.76%
More

OGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, OGN has been loosely correlated with PFE. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if OGN jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OGN
1D Price
Change %
OGN100%
+0.11%
PFE - OGN
42%
Loosely correlated
-1.82%
AMGN - OGN
41%
Loosely correlated
-0.38%
LLY - OGN
39%
Loosely correlated
-0.80%
GSK - OGN
38%
Loosely correlated
-0.66%
BIIB - OGN
36%
Loosely correlated
-0.67%
More